Rajesh Khanna
Overview
Explore the profile of Rajesh Khanna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
3787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chiavaccini L, Santoro D, Dwyer C, Vettorato E, Nelson T, Khanna R
Vet Anaesth Analg
. 2025 Jan;
52(2):257-261.
PMID: 39863517
Burn-related neuropathic pain (BRNP) can arise following burn-induced nerve damage, affects approximately 6% of burned human patients and can result in chronic pain. Although widely studied in humans, data on...
3.
Rodriguez-Palma E, Loya-Lopez S, Allen K, Cruz-Almeida Y, Khanna R
Neurobiol Pain
. 2025 Jan;
17():100177.
PMID: 39850977
Joint pain is the primary symptom of osteoarthritis (OA) and the main motivator for patients to seek medical care. OA-related pain significantly restricts joint function and diminishes quality of life....
4.
Rodriguez-Palma E, Loya-Lopez S, Min S, Calderon-Rivera A, Gomez K, Khanna R, et al.
Neurobiol Pain
. 2024 Dec;
17:100174.
PMID: 39720155
PIKfyve (1-phosphatidylinositol 3-phosphate 5-kinase), a lipid kinase, plays an important role in generating phosphatidylinositol (3,5)-bisphosphate (PI(3,5)P). SGC-PIKFYVE-1, a potent and selective inhibitor of PIKfyve, has been used as a chemical...
5.
Nelson T, Allen H, Khanna R
ACS Pharmacol Transl Sci
. 2024 Dec;
7(12):3718-3728.
PMID: 39698268
Neuropeptide Y (NPY) is a highly conserved neuropeptide with widespread distribution in the central nervous system and diverse physiological functions. While extensively studied for its inhibitory effects on pain at...
6.
Tang C, Gomez K, Chen Y, Allen H, Hestehave S, Rodriguez-Palma E, et al.
J Clin Invest
. 2024 Dec;
135(4).
PMID: 39656529
Antagonists - such as Ziconotide and Gabapentin - of the CaV2.2 (N-type) calcium channels are used clinically as analgesics for chronic pain. However, their use is limited by narrow therapeutic...
7.
Parikh P, Kwami C, Khanna R, Lall M, Reddy H, Benton L, et al.
J Water Sanit Hyg Dev
. 2024 Dec;
11:902-915.
PMID: 39640501
As factors influencing the health and well-being of children are complex and cross-sectoral, integrated interventions are required to improve child health and hence address the Sustainable Development Goals. This paper...
8.
Peach C, Tonello R, Damo E, Gomez K, Calderon-Rivera A, Bruni R, et al.
J Clin Invest
. 2024 Nov;
135(4).
PMID: 39589827
Nerve growth factor (NGF) monoclonal antibodies inhibit chronic pain, yet failed to gain approval due to worsened joint damage in osteoarthritis patients. We report that neuropilin-1 (NRP1) is a coreceptor...
9.
10.
Saez J, Burrell J, Cahill C, Cullen D, Devi L, Gilbert R, et al.
Front Pharmacol
. 2024 Sep;
15:1427147.
PMID: 39346563
Over the past decade, boldine, a naturally occurring alkaloid found in several plant species including the Chilean Boldo tree, has garnered attention for its efficacy in rodent models of human...